LWM
GILD icon

Laidlaw Wealth Management’s Gilead Sciences GILD Stock Holding History

Laidlaw Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Buy
2,866
+1,221
+74% +$161K 1.03% 34
2026
Q1 		$229K Sell
1,645
-263
-14% -$36.8K 0.8% 37
2025
Q4 		$234K Buy
+1,908
New +$232K 0.72% 40
2024
Q1 		– Sell
-3,369
Closed -$273K – 198
2023
Q4 		$273K Buy
3,369
+95
+3% +$7.39K 0.1% 193
2023
Q3 		$245K Buy
3,274
+115
+4% +$8.85K 0.08% 226
2023
Q2 		$243K Sell
3,159
-788
-20% -$62.8K 0.05% 297
2023
Q1 		$328K Sell
3,947
-176
-4% -$14.6K 0.07% 247
2022
Q4 		$354K Sell
4,123
-334
-7% -$26.4K 0.08% 241
2022
Q3 		$275K Sell
4,457
-456
-9% -$28.8K 0.06% 253
2022
Q2 		$304K Buy
4,913
+43
+0.9% +$2.66K 0.06% 263
2022
Q1 		$290K Buy
4,870
+131
+3% +$8.37K 0.05% 306
2021
Q4 		$344K Buy
+4,739
New +$326K 0.06% 280
2021
Q1 		– Sell
-3,693
Closed -$215K – 272
2020
Q4 		$215K Buy
+3,693
New +$223K 0.05% 325
2020
Q2 		– Sell
-3,490
Closed -$261K – 186
2020
Q1 		$261K Buy
+3,490
New +$241K 0.17% 121

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Laidlaw Wealth Management's GILD Position: Q2 2026 in Review

Laidlaw Wealth Management increased its Gilead Sciences (GILD) stake by 74% in Q2 2026, buying an estimated $161K and bringing the position to 2,866 shares worth $362K. The position accounts for 1.03% of the portfolio, ranked #34.

Laidlaw Wealth Management first reported a position in GILD in Q1 2020 and has held it in 14 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Laidlaw Wealth Management held 2,866 shares of Gilead Sciences worth $362K as of Q2 2026.
  • Laidlaw Wealth Management bought 1,221 Gilead Sciences shares in Q2 2026, an estimated $161K.
  • Gilead Sciences made up 1.03% of Laidlaw Wealth Management's portfolio in Q2 2026, its #34 holding.
  • Laidlaw Wealth Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 14 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Laidlaw Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.